Time away from the laboratory/university/clinic is a significant factor for both academic and industrial scientists. Presentation of a lecture or poster at a conference – an activity that takes at most a few hours – typically involves several days away from work, in addition to costs associated with travel, lodging, meals and meeting registration.
United Scientific Group along with Drug Discovery-2020 Team are planning to offer some great content and evidence based information that helps Pharmacists, biologists, chemists, biotechnologists, epidemiologists and other allied experts from academic institutions, government agencies, societies, non-profit organizations and the industry through this online conference.
This Virtual Conference provides the best platform for participants who would otherwise be unable to participate in events of this standard owing to;
We believe that our virtual platform offers the scientific community greater opportunity to share their work in a manner that allows them to devote more of their time and funding to science itself, while minimizing the expenses and retaining the key benefits of an in-person conference such as learning opportunities, sharing of ideas, and networking.
Experience powerful education, learning, innovation by internationally recognized speakers.01
Engage without the expense and hassle of travel and hotel bookings. Spend your funds on Science.02
Accessible from anywhere in the world - Attend any scientific session of your interest.03
Connects pharma heads and biotech researchers from all over the globe to network and to share cutting-edge research.04
The presentations will remain available one month from the date of the live event for increased reach to the global community.05
Get market exposure, promote your new technologies and innovations, Keep your brand front of mind and generate leads.06
Biography : Ram Samudrala is Professor and Chief of the Division of Bioinformatics at the University at Buffalo researching multiscale modelling of protein and proteome structure, function, interaction, design, and evolution across atomic, molecular, cellular, and physiological scales. His work has led to more than 130 publications in journals such as Science, Nature, PLoS Biology, the Proceedings of the National Academy of Sciences, and the Journal of the American Medical Association, as well as freely copiable software and web servers for molecular and systems modelling. Previously, Dr. Samudrala joined the University of Washington faculty in 2001 after completing his postdoctoral work with Michael Levitt (2013 Nobel in Chemistry) at Stanford University. He was named a Searle Scholar in 2002, a top young innovator (TR100) by MIT Technology Review in 2003, presented the University of Washington New Investigator Science in Medicine Lecture in 2004, received the NSF CAREER Award in 2005, the Alberta Heritage Foundation for Medical Research Visiting Scientist Award in 2008, and the NIH Director's Pioneer Award in 2010. In 2019, Samudrala was named an University at Buffalo Exceptional Scholar and also awarded a NIH NCATS ASPIRE Design Challenge Award.
Title of talk: Insights into developing antivirals against SARS-COV2: challenges & progress
Biography : Dr. Reem Al Olaby is currently an assistant professor of biology & biotechnology at California Northstate University – College of Health Sciences. Dr. Al Olaby's research interest lies in merging her experience in drug discovery with her training in the infectious diseases and neuroscience discipline. She aims at developing a library of drug leads that can target neurodegenerative disorders that are based on proteinopathies and alteration in the protein stability system. Furthermore, she is currently working on 2 side projects, one aims at identifying drug leads against malaria and the other aims at identifying drug leads against SARS-COV2.
Title of talk: NemaLife Infinity: A scalable, rapid, whole-organism longevity screening platform for drug discovery and repurposing
Biography : Marton is a published scientist with over a decade of hands-on research in anti-aging and age-associated diseases. After his postdoctoral research, he polished his business skills in a variety of business roles, including sales, marketing, business development, and management consulting. At NemaLife Inc, a spin-off started by his former postdoctoral lab colleagues, he is responsible for Business Development, Investor Relations, and Sales Development. He received his MSc and Ph.D. from Eotvos Lorand University. During his postdoctoral training at Rutgers University and Texas Tech University, he published high impact original research publications in Nature, Lab on Chip, and Journal of Neuroscience.
We are ready to lead you into the future of virtual conferences!
Use the below form to drops us an email. We will be in touch with lightning speed.